Regeneron

Evkeeza

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Regeneron

Evkeeza HCPCS:

J1305

HCPCS Code Descriptor:

Injection, evinacumab-dgnb, 5mg

Category:

J Code

Evkeeza NDCs:

61755-0010-01, 61755-0013-01

Primary Type:

Cardiology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Evkeeza CPT Codes:

Potential CPT administration codes for Evkeeza can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Evkeeza:

Evkeeza is a Cardiology drug manufactured by Regeneron and administered via the Intravenous route of administration. The J Code: J1305 is aligned to the drug Evkeeza.

ACCESS PRICING AND MORE BY REGISTERING

J1305 Added Date:

October 1, 2021

J1305 Effective Date:

October 1, 2021

J1305 Termination Date:

HCPCS Active

Evkeeza billing and coding information can be found through Regeneron at the link below:
Evkeeza patient assistance information can be found through Evkeeza Patient Support at the URL: https://evkeeza.com/patient-support
Evkeeza prescribing information can be found at the link below:
Information regarding Evkeeza’s side effects can be found at MedlinePlus